Gene therapy for rare blindness passes 5-year safety check
Knowledge-focused
Completed
This study followed 87 people who had already received Luxturna gene therapy for a rare inherited eye condition that can cause blindness. The goal was to watch for any side effects over 5 years after treatment. No new treatment was given; researchers simply collected safety infor…
Sponsor: Spark Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 18, 2026 03:03 UTC